Research Topics
Genomes and Genes | S H RalstonSummaryAffiliation: University of Aberdeen Country: UK Publications
| Collaborators
|
Detail Information
Publications
Bone densitometry and bone biopsyStuart H Ralston
Bone Research Group, Institute of Medical Sciences, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, UK
Best Pract Res Clin Rheumatol 19:487-501. 2005..Under these circumstances it is an invaluable investigation that can be used to differentiate infiltrative disorders from primary abnormalities of osteoblast or osteoclast function...
Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandinsS H Ralston
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, UK
Bone 19:29-33. 1996....
Genetic control of susceptibility to osteoporosisStuart H Ralston
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK
J Clin Endocrinol Metab 87:2460-6. 2002....
Medical management of hypercalcemiaS H Ralston
Department of Medicine and Bone Metabolism, University of Aberdeen, AB25 2ZD, UK
Calcif Tissue Int 74:1-11. 2004
Genetic determinants of susceptibility to osteoporosisStuart H Ralston
University of Aberdeen Medical School, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
Curr Opin Pharmacol 3:286-90. 2003..Information from these studies is being used to design new drugs for osteoporosis and to develop genetic markers for fracture risk assessment...
COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapyA M Qureshi
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom
Calcif Tissue Int 70:158-63. 2002..Our data raise the possibility that COLIA1 genotyping could be used to target etidronate therapy to those most likely to respond in terms of FN BMD, with potential benefits in terms of economic cost and clinical outcome...
COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone lossH M Macdonald
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, United Kingdom
J Bone Miner Res 16:1634-41. 2001..0%), weight (5.0%), and baseline BMD (2.8%). We conclude that women homozygous for the Sp1 polymorphism are at significantly increased risk of excess rates of bone loss at the spine, but this effect may be nullified by the use of HRT...
Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of boneO M E Albagha
The Bone Research Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
J Med Genet 42:240-6. 2005..The gene encoding oestrogen receptor alpha (ESR1) appears to regulate bone mineral density (BMD) and other determinants of osteoporotic fracture risk...
A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and qualityV Mann
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Clin Invest 107:899-907. 2001..We conclude that the COL1A1 Sp1 polymorphism is a functional genetic variant that predisposes to osteoporosis by complex mechanisms involving changes in bone mass and bone quality...
Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosisK J Armour
University of Aberdeen Medical School, UK
Arthritis Rheum 44:2790-6. 2001..CONCLUSION: Inducible NOS-mediated osteoblast apoptosis and depressed bone formation play important roles in the pathogenesis of IMO...
Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026)K J Armour
University of Aberdeen Medical School, UK
Arthritis Rheum 44:2185-92. 2001..We conclude that HCT1026 may be of clinical value in the prevention and treatment of inflammatory diseases such as rheumatoid arthritis, which are characterized by joint inflammation as well as periarticular and systemic bone loss...
Association between COLIA1 Sp1 alleles and femoral neck geometryA M Qureshi
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, UK
Calcif Tissue Int 69:67-72. 2001..The association COLIAI genotype and increased femoral neck angle noted here may therefore contribute to the BMD-independent increase in hip fracture risk noted in previous studies of individuals who carry the 's' allele...
Prediction of osteoporotic fractures by bone densitometry and COLIA1 genotyping: a prospective, population-based study in men and womenF E McGuigan
Department of Medicine and Therapeutics, Foresterhill, Aberdeen, UK
Osteoporos Int 12:91-6. 2001..We conclude that in our population, COLIA1 genotyping predicts fractures independently of bone mass and interacts with bone densitometry to help identify women who are at high and low risk of sustaining osteoporotic fractures...
Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral densityH M Macdonald
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Bone 35:957-64. 2004..This raises the possibility that riboflavin intake and MTHFR genotype might interact to regulate BMD. Further work is required to determine if this association holds true for other populations and ethnic groups...
Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralization in vivoT L Stewart
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Aberdeen, AB25 2ZD, UK
Calcif Tissue Int 77:113-8. 2005..This suggests that the increased bone fragility in carriers of the COLIA1 Sp1 allele may result in part from defects in bone mineralization...
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthaseK E Armour
Department of Medicine and Therapeutics, Foresterhill, University of Aberdeen Medical School, Aberdeen, AB25 2ZD, United Kingdom
Endocrinology 142:760-6. 2001..We conclude that the eNOS pathway plays an essential role in regulating bone mass and bone turnover by modulating osteoblast function...
Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosisD M Reid
Department of Medicine and Therapeutics, Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Osteoporos Int 17:125-32. 2006....
Nitric oxide and boneR J van't Hof
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
Immunology 103:255-61. 2001..These data indicate that the L-arginine/NO pathway represents a novel target for therapeutic intervention in the prevention and treatment of bone diseases...
Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UKP N Tasker
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
Osteoporos Int 17:1078-85. 2006..Whilst further studies will be required to confirm and extend these observations, our studies raise the possibility that A99T heterozygosity might affect lysyl hydroxylase function and regulate bone mass...
Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fractureV Mann
Bone Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK
Bone 32:711-7. 2003..We conclude that the COL1A1 Sp1 alleles are associated with a modest reduction in BMD and a significant increase in risk of osteoporotic fracture, particularly vertebral fracture...
Management of Paget's disease of boneA L Langston
Health Services Research Unit, University of Aberdeen, UK
Rheumatology (Oxford) 43:955-9. 2004....
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35L J Hocking
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Aberdeen AB25 2ZD, United Kingdom
Am J Hum Genet 69:1055-61. 2001..47 at D5S2034 (187.8 cM). These data indicate the presence of several susceptibility loci for PDB and identify a strong candidate locus for the disease, on chromosome 5q35...
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemiaS H Ralston
University of Aberdeen, UK
Br J Cancer 75:295-300. 1997..We conclude that ibandronate is a safe, well tolerated and effective treatment for cancer-associated hypercalcaemia, which should prove a useful addition to the current range of therapies available to treat this condition...
Detection of nitric oxide and nitric oxide synthases in psoriasisA D Ormerod
Department of Dermatology, University of Aberdeen, UK
Arch Dermatol Res 290:3-8. 1998....
Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorptionR J van't Hof
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
Proc Natl Acad Sci U S A 97:7993-8. 2000..These results show that the iNOS pathway is essential for IL-1-induced bone resorption and suggest that the effects of NO may be mediated by modulating IL-1-induced nuclear activation of NFkappaB in osteoclast precursors...
Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United KingdomO M Albagha
Department of Medicine and Therapeutics, University of Aberdeen Medical School, UK
J Bone Miner Res 16:128-34. 2001....
Cytokine-activated endothelium recruits osteoclast precursorsN W McGowan
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom
Endocrinology 142:1678-81. 2001..These results provide the first evidence that osteoclast precursors can adhere to endothelium and suggest that endothelium could play an important role in the recruitment of osteoclast precursors to sites of bone resorption...
Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failureP Abraham
Department of Endocrinology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK
Postgrad Med J 78:752-3. 2002..A raised PTHrP concentration is a strong indicator of malignancy...
Pharmacological management of back pain syndromesR W Porter
University of Aberdeen, Department of Orthopaedics, Scotland
Drugs 48:189-98. 1994..Other drugs which may be useful in relieving back pain associated with specific circumstances include the tricyclic antidepressants, anxiolytics, antiepileptic agents, corticosteroids, colchicine and chymopapain...
The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide productionA I Idris
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
Bone 35:636-43. 2004..This demonstrates that HCT1026 and derivatives could represent a novel class of antiresorptive drugs with therapeutic value in the treatment of bone diseases associated with accelerated bone loss due to osteoclast activation...
Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneityS I Haslam
Department of Medicine and Therapeutics, University of Aberdeen, United Kingdom
J Bone Miner Res 13:911-7. 1998..Data from three families did not support evidence of linkage to 18q21-22 however, indicating that Paget's disease is genetically heterogeneous and suggests the presence of at least one additional locus which remains to be discovered...
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 geneS F Grant
Department of Medicine and Therapeutics, University of Aberdeen, UK
Nat Genet 14:203-5. 1996....
Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?J S McLay
Department of Medicine and Therapeutics, Aberdeen University Medical School, Foresterhill, Scotland, United Kingdom
Kidney Int 46:1043-9. 1994..The results of this study clearly show that human proximal tubular cells, in primary culture, are capable of producing nitric oxide in response to an immune challenge secondary to the induction of nitric oxide synthase...
Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22Claire A Parsons
Bone Research Group, University of Aberdeen, UK
Hum Mol Genet 14:3141-8. 2005..002). Our study illustrates that interspecies synteny can be used to identify and refine QTL for complex traits and represents the first example where a human QTL for BMD regulation has been mapped using this approach...
Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in womenTracy L Stewart
Rheumatic Diseases Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
J Clin Endocrinol Metab 91:3575-83. 2006..The COLIA1 gene is a strong candidate for susceptibility to osteoporosis. The causal genetic variants are currently unclear, but the most likely are functional polymorphisms in the promoter and intron 1 of COLIA1...
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS studyStuart H Ralston
Rheumatic Diseases Unit, University of Edinburgh, Western General Hospital Edinburgh, Edinburgh, United Kingdom
PLoS Med 3:e90. 2006....
Genetic determinants of osteoporosisStuart H Ralston
Department of Rheumatology, Rheumatic Diseases Unit, Edinburgh University Western General Hospital, Edinburgh, United Kingdom
Curr Opin Rheumatol 17:475-9. 2005..Several advances have been made over recent years in understanding the genetic basis of susceptibility to osteoporosis. This paper will review recent developments in this area...
An integrated approach to consumer representation and involvement in a multicentre randomized controlled trialAnne L Langston
Health Services Research Unit, University of Aberdeen, Aberdeen, UK
Clin Trials 2:80-7. 2005..Adoption of such an approach in other trials may yield significant improvements in recruitment and quality of participant information flow. There are, however, resource implications for both parties...
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of boneGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, UK
Bone 38:280-5. 2006..Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia...
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were avAnne L Langston
Health Services Research Unit, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK
BMC Health Serv Res 6:71. 2006..The Theory of Planned Behaviour is a theoretical model that predicts behaviours from people's beliefs about the consequences, social pressures and perceived control over the behaviour, including uptake of treatment...
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysisAndre G Uitterlinden
Erasmus MC, Rotterdam, The Netherlands
Ann Intern Med 145:255-64. 2006..Polymorphisms of the vitamin D receptor (VDR) gene have been implicated in the genetic regulation of bone mineral density (BMD). However, the clinical impact of these variants remains unclear...
Mechanisms of disease: genetics of Paget's disease of bone and related disordersAnna Daroszewska
University of Edinburgh, UK
Nat Clin Pract Rheumatol 2:270-7. 2006....
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphismsHelen M Macdonald
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom
Am J Clin Nutr 87:1513-20. 2008..Polymorphisms in the apolipoprotein E (APOE) gene are associated with fracture risk, and a potential mechanism is through vitamin K transport...
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS studyBente L Langdahl
Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
Bone 42:969-81. 2008....
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitroAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh EH4 2XU, UK
Calcif Tissue Int 82:191-201. 2008..This raises the possibility that inhibition of bone formation by bisphosphonates may be due in part to a direct inhibitory effect on cells of the osteoblast lineage...
Advances in the molecular pharmacology and therapeutics of bone disease and International Symposium on Paget's Disease July 10-14, 2007 St. Catherine's College, Oxford, UKStuart H Ralston
Department of Medicine, University of Edinburgh, UK
Bone 41:1059-62. 2007
PTHR1 polymorphisms influence BMD variation through effects on the growing skeletonCarles Vilariño-Güell
Institute of Musculoskeletal Sciences, Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington, Oxford, UK
Calcif Tissue Int 81:270-8. 2007..006) and total body less head BMD (P = 0.02), corrected for age and gender, confirming the family findings. These findings suggest a role for PTHR1 variation in determining peak BMD...
Genetics of osteoporosisStuart H Ralston
Molecular Medicine Centre, Rheumatic Diseases Unit, Edinburgh University, Western General Hospital, Edinburgh EH4 2XU, UK
Proc Nutr Soc 66:158-65. 2007....
Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of boneGreet Beyens
Department of Medical Genetics, University and University Hospital of Antwerp, Antwerp, Belgium
J Bone Miner Res 22:1062-71. 2007..We observed no association in men, but a highly significant association was found in women, and this was confirmed in a population from the United Kingdom...
Genetics and osteoporosisOmar M E Albagha
Rheumatology Section, Molecular Medicine Centre, University of Edinburgh School of Molecular and Clinical Medicine, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom
Rheum Dis Clin North Am 32:659-80. 2006..They could be developed as diagnostic genetic tests or form molecular targets for design of new drugs for the prevention and treatment of osteoporosis and other bone diseases...
Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorptionIain R Greig
School of Medicine, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
J Med Chem 49:7487-92. 2006..In conclusion, biphenylsulfonamides like 55 form a new class of potent antiresorptive agents with possible therapeutic use in diseases characterized by increased bone resorption...
Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in womenFiona E A McGuigan
Department of Medicine and Therapeutics, University of Aberdeen, UK
J Bone Miner Res 22:195-202. 2007..We studied five common polymorphisms of TGFB1 in relation to osteoporosis-related phenotypes in a population-based cohort of 2975 British women, but found no significant association with bone mass, bone loss, bone markers, or fracture...
Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritabilityBlair H Smith
University of Aberdeen, Department of General Practice and Primary Care, Foresterhill Health Centre, Westburn Road, Aberdeen, UK
BMC Med Genet 7:74. 2006....
Genetic regulation of bone mass and susceptibility to osteoporosisStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
Genes Dev 20:2492-506. 2006....
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were avaAnne L Langston
Edinburgh Clinical Trials Unit, University of Edinburgh, Queens Medical Research Institute, Room E1, 16, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
BMC Health Serv Res 8:116. 2008..Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour...
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptorsAymen I Idris
Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Nat Med 11:774-9. 2005....
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosisAnna Taranta
Istituto Dermopatico dell'Immacolata, Rome, Italy
Am J Pathol 162:57-68. 2003..Bone marrow transplantation was successful in all patients, and posttransplant osteoclasts showed rescue of a3 subunit immunoreactivity...
Genetic determinants of susceptibility to osteoporosisOmar M E Albagha
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Aberdeen AB25 2ZD, UK
Endocrinol Metab Clin North Am 32:65-81, vi. 2003....
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysisJohn P A Ioannidis
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece
J Bone Miner Res 17:2048-60. 2002..In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism is not associated with either BMD or fracture risk...
Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal womenJohn Somner
Department of Chemical Pathology, St Thomas Hospital, London, SE1 7EH United Kingdom
J Clin Endocrinol Metab 89:344-51. 2004..012). Subjects with the CC genotype had significantly lower BMD (mean +/- SD: TT, 0.7 +/- 0.16; CC, 0.6 +/- 0.08 g/cm(2); P = 0.006). In conclusion, both CYP 17 and CYP 19 are candidate genes for osteoporosis in postmenopausal women...
Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from ScotlandFabienne S Giraudeau
Department of Discovery Genetics, GlaxoSmithKline Research and Development, New Frontiers Science Park, Harlow, United Kingdom
J Bone Miner Res 19:31-41. 2004..We present a thorough analysis of common CTSK polymorphisms and genetic relatedness among CTSK haplotypes...
RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass indexTanya Vaughan
School of Health Science, Griffith University Gold Coast Campus, 4215 Queensland, Australia
Bone 34:1029-36. 2004..Glutamine variants and an alanine insertion were identified within the group. These data suggest that the RUNX2 alleles are associated with BMD in a menopause- and weight-dependent manner...
Regulation of bone mass and bone turnover by neuronal nitric oxide synthaseRobert J van't Hof
Bone Research Group, Institute of Medical Sciences, Department of Medicine and Therapeutics, Foresterhill, Aberdeen AB25 2ZD, United Kingdom
Endocrinology 145:5068-74. 2004..The low level of nNOS expression in bone and the in vitro behavior of nNOS KO bone cells indicate that these actions are indirect and possibly mediated by a neurogenic relay...
Influence of LRP5 polymorphisms on normal variation in BMDM Audrey Koay
Institute of Musculoskeletal Sciences, University of Oxford, The Botnar Research Centre, Nuffield Orthopaedic Centre, Headington, Oxford, UK
J Bone Miner Res 19:1619-27. 2004....
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitorsAymen I Idris
Bone Research Group, Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
J Bone Miner Res 19:1651-60. 2004....
Genetic and environmental determinants of peak bone mass in young men and womenFiona E A McGuigan
Aberdeen University, Scotland, UK
J Bone Miner Res 17:1273-9. 2002....
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS studyStuart H Ralston
Rheumatic Diseases Unit, University of Edinburgh Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, UK
Hum Mol Genet 14:943-51. 2005..This study provides evidence for gender-specific, site-specific and age-specific QTL, which regulate BMD in humans, and illustrates the importance of conducting subgroup analysis to detect these loci...
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descentGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 20:227-31. 2005..Here we show that the most common disease-causing mutation (P392L) is carried on a shared haplotype, consistent with a founder effect and a common ancestral origin...
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomesJohn P A Ioannidis
Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
JAMA 292:2105-14. 2004..Estrogen receptor alpha (ESR1) is a candidate gene for osteoporosis, but previous studies of ESR1 polymorphisms in this field were hampered by small sample size, lack of standardization, and inconclusive results...
Evolution of understanding of genetics of Paget's disease of bone and related diseasesShinjiro Takata
Department of Orthopedics, The University of Tokushima School of Medicine, 3-18-15 Kuramoto-cho, Tokushima, Japan
J Bone Miner Metab 22:519-23. 2004
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal womenOmar M E Albagha
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, UK
Hum Mol Genet 11:2289-95. 2002..In summary, our work supports the view that allelic variation in the 3'UTR of TNFRSF1B gene contributes to the genetic regulation of bone mass, with effects that are specific for femoral neck BMD...
Increased bone resorption in the critically ill: association with sepsis and increased nitric oxide productionLorna M Smith
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill Aberdeen, UK
Crit Care Med 30:837-40. 2002..High concentrations of nitric oxide generated during the course of infection do not afford significant protection against accelerated bone resorption...
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosisJoyce B J van Meurs
Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
JAMA 299:1277-90. 2008..Mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) gene cause rare syndromes characterized by altered bone mineral density (BMD). More common LRP5 variants may affect osteoporosis risk in the general population...
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switchJed Long
School of Chemistry, Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, United Kingdom
J Biol Chem 283:5427-40. 2008..The conformational switch observed on binding may represent a novel mechanism that underlies specificity in regulating signalinduced protein recognition events...
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfectaThomas S Lisse
Institute of Experimental Genetics, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany
PLoS Genet 4:e7. 2008....
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's diseaseLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, UK
Hum Mol Genet 11:2735-9. 2002..0001). These studies confirm that mutations affecting the ubiquitin-binding domain of SQSTM1 are a common cause of familial and sporadic Paget's disease of bone...
ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathwaysAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh, EH4 2XU, UK
Biochem Biophys Res Commun 371:94-8. 2008....
Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disordersStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Edinburgh, UK
Best Pract Res Clin Rheumatol 22:101-11. 2008..Anecdotal reports indicate that osteoclast inhibitors such as bisphosphonates are effective for suppressing bone turnover and improving symptoms in these disorders, although the long-term effects on clinical outcomes are unclear...
The pro and con of measles virus in Paget's disease: conBert K Rima
J Bone Miner Res 17:2290-2; author reply 2293. 2002
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens
Department of Medical Genetics, University of Antwerp, 2610 Antwerp, Belgium
J Biol Chem 278:7718-24. 2003..Our data indicate that the mutations in the signal peptide and latency-associated peptide facilitate TGF-beta1 signaling, thus causing Camurati-Engelmann disease...
Genetics of osteoporosisHuilin Jin
University of Aberdeen Medical School, Department of Medicine and Therapeutics, University of Aberdeen, AB25 2ZD, UK
Curr Rheumatol Rep 7:66-70. 2005....
Genetics of Paget's disease of boneAnna Daroszewska
Institute of Medical Sciences, University of Aberdeen Medical School, Aberdeen AB25 2ZD, UK
Clin Sci (Lond) 109:257-63. 2005....
Polymorphisms of the CLCN7 gene are associated with BMD in womenUlrika Pettersson
Bone Research Group, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom
J Bone Miner Res 20:1960-7. 2005..Our study adds to accumulating evidence that shows that common allelic variants in monogenic bone disease genes often contribute to BMD regulation in normal subjects...
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerinAnna Daroszewska
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
J Bone Miner Res 19:1506-11. 2004..We found that the G1181 allele of TNFRSF11B, encoding lysine at codon 3 of the OPG protein, predisposes to both sporadic and familial PDB...
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequencesLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 19:1122-7. 2004..Functional and structural analysis showed that disease severity was related to the type of mutation but was unrelated to the polyubiquitin-binding properties of the mutant UBA domain peptides...
Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracturePaul N Tasker
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, AB25 2ZD, Aberdeen, UK
Osteoporos Int 15:903-8. 2004....
A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitroNeil W A McGowan
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
J Clin Endocrinol Metab 88:3321-6. 2003..The activation of osteoclast activity noted here is consistent with clinical reports that have shown biochemical evidence of increased bone resorption as well as bone formation in CED...
Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of boneStuart H Ralston
Rheumatic Diseases Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK
J Bone Miner Res 22:569-77. 2007....
Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone massJohn P A Ioannidis
Department of Hygiene and Epidemology, University of Ioannina School of Medicine, Ioannina, Greece
J Bone Miner Res 22:173-83. 2007..Evidence was gained to suggest that several chromosomal loci regulate BMD in a site-specific and sex-specific manner...
Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disordersGavin J A Lucas
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom
J Bone Miner Res 21:P31-7. 2006..In light of the molecular defects that have been identified thus far, it seems likely that these genes will also be involved in the RANK-NF-kappaB signaling pathway or its interactions with the ubiquitin-proteasome system...
Pathogenesis and management of Paget's disease of boneStuart H Ralston
Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
Lancet 372:155-63. 2008..No firm evidence as yet exists to show that bisphosphonates can prevent the development of complications of Paget's disease of bone, and further work is needed to address the effects of treatment on long-term clinical outcome...
